Objective:To investigate the safety of Ciprofloxacin-Dexamethasone (CIP, 2 mg) and the effects of 2 mg Ciprofloxacin and dexamethasone on the growth and proliferation of human colon tumor cell lines. The purpose of this study was to compare the effect of CIP and dexamethasone on the proliferation of human colon tumor cells.
Methods:Clinical studies were performed in adult patients with colon adenocarcinoma (n = 60). Patients were randomly assigned to CIP (Ciprofloxacin 2 mg, 1 mg) or dexamethasone (Dexamethasone 1 mg, 2 mg). Tumor cells were seeded on day 0, 3, 5, 8, and 10 in 24-well plates. After 24 hours, growth was determined using an MTT method. The cells were treated with CIP (Ciprofloxacin 2 mg), dexamethasone (Dexamethasone 1 mg), or no drug for 24 hours. The cell proliferation was measured using MTT assay. The results were expressed as the mean ± SD, with N=5 per group.
Results:CIP significantly inhibited the growth and proliferation of colon tumor cells (MTT), but there was no significant difference between the two groups. Ciprofloxacin 1 mg treatment significantly inhibited the growth and proliferation of colon tumor cells. Compared with the control group, dexamethasone treatment significantly inhibited the growth and proliferation of colon tumor cells, and CIP significantly inhibited the proliferation of colon tumor cells. The effect of 2 mg CIP on the proliferation of colon tumor cells was statistically significant compared with dexamethasone, and there was no significant difference between the two groups.
Conclusions:Ciprofloxacin-Dexamethasone (CIP, 2 mg) and dexamethasone (Dexamethasone 1 mg, 2 mg) have no negative effects on the growth and proliferation of colon tumor cells. The effects of 2 mg CIP on the proliferation of colon tumor cells may be due to the inhibition of the cell proliferation.
Key messages:Ciprofloxacin-Dexamethasone (CIP) and dexamethasone (Dexamethasone 1 mg) inhibit the growth and proliferation of human colon tumor cells. Ciprofloxacin-Dexamethasone (CIP) and dexamethasone (Dexamethasone 1 mg) decrease the secretion of pro-apoptotic factors and modulate apoptosis.
Tumor cell growth is a major contributor to tumor invasion and metastasis, as it is the predominant component of the tumor microenvironment [,]. It is believed that the cancer cell growth is driven by cell cycle, as the cell is stimulated for the formation of new tumors []. Ciprofloxacin-Dexamethasone (CIP, 2 mg) and dexamethasone (Dexamethasone 1 mg) are considered to be the most effective drugs used in the treatment of chronic infection, including tuberculosis, tuberculosis infection, and HIV/AIDS. These drugs inhibit the growth of colon tumor cells by inhibiting caspase-3 and -8 [, ]. However, the clinical effect of these drugs is not well-established and it is not well-established that they inhibit the proliferation of colon tumor cells []. Dexamethasone (Dexamethasone 1 mg) is a corticosteroid and is effective for the treatment of tuberculosis infection [].
In this study, we examined the effects of 2 mg CIP and dexamethasone on the proliferation of human colon tumor cells.
Ciprofloxacin, a fluoroquinolone antibiotic belonging to the fluoroquinolone class, was previously characterized as a fluoroquinolone antibiotic []. The original ciprofloxacin was originally synthesized by Riedel and colleagues. It was then developed by the pharmaceutical company Riedel []. The original ciprofloxacin is a synthetic quinolone antibiotic, and it was then synthesized by several different laboratories. The quinolones have been widely used in various laboratories, including pharmaceutical companies, biochemists, and molecular biology laboratories [, ].
Urinary tract infection (UTI) is a serious and potentially fatal infection which is caused by infections of the urinary tract. The most common cause of infection in women and men is the common UTI (Table 1). The incidence of UTIs and related complications in women is about 5% in the general population and 1% in the general population, depending on the population studied and the study population. UTI can have several clinical and physiological consequences. Some of the most common causes of UTI are the following: urinary tract infections (UTIs); prostatitis, prostatoma (a disease which causes pain, inflammation and pain), prostatitis associated with urinary retention or infections; infections of the blood and lymphatic systems including infections of the brain, spinal cord, and lung (infections of the blood and/or of the liver) caused by a bacterial infection, such as trichomoniasis. In order to avoid the development of UTI, the treatment with the commonly used drugs tetracycline (tetracycline-antibiotic) or minocycline (minocycline-antibiotic) is recommended.
Table 1Adverse events
The diagnosis of UTI can be made by a physician who is knowledgeable in the local or systemic conditions. The patient's medical history, especially of the history of recurrent UTIs, can be gathered in a medical history review. In most cases, the UTI is defined as a history of recurrent UTI, regardless of whether the patient is a first-episode or recurrent episode. The diagnosis of UTI may also be made based on the clinical manifestations and the results of an appropriate laboratory tests.
UTI is a serious and potentially fatal infection which is caused by infections of the urinary tract. The infection is most often the result of the following: urinary tract infections (UTIs) such as bladder, urethra and prostate infections. The incidence of urinary tract infections in women is about 5% in the general population and 1% in the general population, depending on the population studied and the study population. Most common UTIs are caused by bacteria of the urinary tract (Table 2).
Table 2. Urinary tract infections in women and men
In most cases, the therapy is recommended by the doctor. In some cases, the doctor may prescribe antibiotics such as amoxicillin or ciprofloxacin (Cipro) for the treatment of UTI. In these cases, antibiotics can be used in a different way than with antibiotics in the previous regimen.
Some of the antibiotics used in the treatment of UTI are listed in Table 3. They are based on clinical data and can only be used as recommended by the doctor. The antibiotics used in the treatment of UTI have been shown to have bactericidal activity against some gram-positive and gram-negative bacteria such as Escherichia coli, Clostridium difficile and Proteus mirabilis. However, in the case of susceptible bacteria, antibiotic resistance has also been reported. Therefore, in this case, the antibiotics used should be used with caution in these patients.
Table 3. Antibiotics used in the treatment of UTI
In most cases, UTI is caused by infections of the urinary tract (urinary tract). However, it can have several possible consequences in cases of UTI such as:
The infection can also lead to the development of prostatitis, which is a disease which causes pain, inflammation and pain in the urethra and prostate. Some of the most common prostatitis are caused by bacteria of the urinary tract (urinary tract infections) such as urinary tract infections associated with urinary retention or infections of the bladder. In this case, antibiotic therapy should be used in a different way than with antibiotics in the previous regimen.
Ophthalmic ciprofloxacin comes as a solution (liquid) to apply to the eyes. Ciprofloxacin ophthalmic solution is usually used often, between once every 15 minutes to once every four hours while awake for seven to 14 days or longer. Ciprofloxacin ophthalmic ointment is usually applied three times a day for two days and then twice a day for five days. Use ciprofloxacin ophthalmic at around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use ciprofloxacin ophthalmic exactly as directed. Do not use it more often than prescribed by your doctor.
You should expect your symptoms to improve during your treatment. Call your doctor if your symptoms do not go away or get worse, or if you develop other problems with your eyes during your treatment.
Use ophthalmic ciprofloxacin until you finish the prescription, even if you feel better. If you stop using ophthalmic ciprofloxacin too soon, your infection may not be completely cured and the bacteria may become resistant to antibiotics.
To instill the eye drops, follow these steps:
Wash your hands thoroughly with soap and water.
Check the dropper tip to make sure that it is not chipped or cracked.
Avoid touching the dropper tip against your eye or anything else; eyedrops and droppers must be kept clean.
While tilting your head back, pull down the lower lid of your eye with your index finger to form a pocket.
Hold the dropper (tip down) with the other hand, as close to the eye as possible without touching it.
Brace the remaining fingers of that hand against your face.
While looking up, gently squeeze the dropper soa single drop falls into the pocket made by the lower eyelid. Remove your index finger from the lower eyelid.
Close your eye for two to three minutes and tip your head down as though looking at the floor. Try not to blink or squeeze your eyelids.
Place a finger on the tear duct and apply gentle pressure.
Wipe any excess liquid from your face with a tissue.
If you are to use more than one drop in the same eye, wait at least five minutes before instilling the next drop.
Replace and tighten the cap on the dropper bottle. Do not wipe or rinse the dropper tip.
Wash your hands to remove any medication.
To apply the eye ointment, follow these instructions:
Avoid touching the tip of the tube against your eye or anything else; the tube tip must be kept clean.
Holding the tube between your thumb and forefinger, place it as near to your eyelid as possible without touching it.
Tilt your head backward slightly.
With your index finger, pull the lower eyelid down to form a pocket.
Squeeze a 1/2-inch (1.25cm) ribbon of ointment into the pocket made by the lower eyelid.
Blink your eye slowly; then gently close your eye for one to two minutes.
With a tissue, wipe any excess ointment from the eyelids and lashes. With another clean tissue, wipe the tip of the tube clean.
Replace and tighten the cap right away.
Joseph R. Suss, MD, FACOEP, FHFA, HSE, HSAO.
Suss, M. D., M. A., FASCO, FHFA, HSE, HSAO.
₹25.76Original price was: ₹25.76.23.20Current price is: ₹23.20.
Ciprofloxacin is an antibiotic used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It belongs to the fluoroquinolone class of antibiotics, and it works by stopping the growth of bacteria. Ciprofloxacin is commonly used to treat a wide range of bacterial infections, including urinary tract infections, skin and soft tissue infections, respiratory tract infections, and sexually transmitted infections. It may also be used for purposes other than those listed in this guide.
Note:This information is intended only for use with your specific medical condition and may not cover all possible uses and limitations. The information is not intended as a substitute for professional medical advice. You should not rely upon the content of this website or its support for any medical advice or treatment.
GivenUsedForBacterial InfectionQuinolonecycloparadolPregnancy and Breastfeeding
This is a generic version of Ciprofloxacin. It is not intended for use in pregnant or breastfeeding women. Please consult a physician before using this medication.
Drug Uses:Ciprofloxacin is primarily prescribed for the treatment of:
Side Effects:
Warnings:This medication should not be taken by pregnant or breastfeeding women. Caution is advised for children under the age of 8 years.
Not For AdultsPregnancyThis medication is not recommended for pregnant or breastfeeding women.
Although uncommon, adverse reactions associated with this medication are described in detail in the manufacturer's product information. It is important to note that most of the reactions are mild and temporary, and may go away without medical intervention in the future.
Ciprofloxacin (in each sealed container of 30 ml) is a broad-spectrum antibiotic that belongs to the fluoroquinolone class. It is effective against a wide range of bacterial infections, including middle ear, sinus, lung, skin, urinary tract, and sexually transmitted diseases. It is also used to treat certain infections in children and adolescents. Ciprofloxacin has been shown to be effective against a wide range of infections, including both acute and chronic urinary tract infections. In addition to its primary use, Ciprofloxacin is also indicated in treating certain types of pneumonia and certain types of infections in the bones. Ciprofloxacin has also been shown to be useful in the treatment of acute bacterial sinusitis. It is also indicated to be used as an empirical treatment of acute bacterial sinusitis in children. Ciprofloxacin belongs to the fluoroquinolone class of antibiotics and is effective against a wide range of bacterial infections, including those caused by bacteria sensitive to the antibiotic. It can also be used to treat certain types of infections in the ear and skin.
The dosage form of Ciprofloxacin is tablet, capsule, or sub-lingual tablet and oral suspension.
Stade de France Pharmacy